[Treatment with imatinib for refractory PAH]

MeSH terms

• Animals
• Apoptosis / drug effects
• Becaplermin
• Benzamides / pharmacology*
• Benzamides / therapeutic use*
• Cell Proliferation / drug effects
• Clinical Trials as Topic
• Female
• Gene Expression / drug effects
• Humans
• Hypertension, Pulmonary / drug therapy*
• Hypertension, Pulmonary / genetics*
• Imatinib Mesylate
• Male
• Middle Aged
• Molecular Targeted Therapy*
• Muscle, Smooth, Vascular / cytology
• Muscle, Smooth, Vascular / drug effects
• Piperazines / pharmacology*
• Piperazines / therapeutic use*
• Protein Kinase Inhibitors / pharmacology*
• Protein Kinase Inhibitors / therapeutic use*
• Proto-Oncogene Proteins c-sis / genetics
• Proto-Oncogene Proteins c-sis / physiology
• Pulmonary Artery / drug effects
• Pulmonary Veno-Occlusive Disease / drug therapy
• Pyrimidines / pharmacology*
• Pyrimidines / therapeutic use*
• Receptors, Platelet-Derived Growth Factor / antagonists & inhibitors
• Vasoconstriction / drug effects